Ilaria Mannucci,Nghi D. P. Dang,Hannes Huber,Jaclyn B. Murry,Jeff Abramson,Thorsten Althoff,Siddharth Banka,Gareth Baynam,David Bearden,Ana Beleza-Meireles,Paul J. Benke,Siren Berland,Tatjana Bierhals,Frederic Bilan,Laurence A. Bindoff,Geir Julius Braathen,Øyvind L. Busk,Jirat Chenbhanich,Jonas Denecke,Luis F. Escobar,Caroline Estes,Julie Fleischer,Daniel Groepper,Charlotte A. Haaxma,Maja Hempel,Yolanda Holler-Managan,Gunnar Houge,Adam Jackson,Laura Kellogg,Boris Keren,Catherine Kiraly-Borri,Cornelia Kraus,Christian Kubisch,Gwenael Le Guyader,Ulf W. Ljungblad,Leslie Manace Brenman,Julian A. Martinez-Agosto,Matthew Might,David T. Miller,Kelly Q. Minks,Billur Moghaddam,Caroline Nava,Stanley F. Nelson,John M. Parant,Trine Prescott,Farrah Rajabi,Hanitra Randrianaivo,Simone F. Reiter,Janneke Schuurs-Hoeijmakers,Perry B. Shieh,Anne Slavotinek,Sarah Smithson,Alexander P. A. Stegmann,Kinga Tomczak,Kristian Tveten,Jun Wang,Jordan H. Whitlock,Christiane Zweier,Kirsty McWalter,Jane Juusola,Fabiola Quintero-Rivera,Utz Fischer,Nan Cher Yeo,Hans-Jürgen Kreienkamp,Davor Lessel

Abstract:Abstract Background We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30 -associated neurodevelopmental disorder. Methods Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30 -deficient HEK293T and zebrafish models, along with in vivo behavioral assays. Results We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30 -deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype. Conclusions Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.

Variant-specific pathophysiological mechanisms of AFF3 differently influence transcriptome profiles

Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination

Spliceosome malfunction causes neurodevelopmental disorders with overlapping features

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

FOXI3 pathogenic variants cause one form of craniofacial microsomia

Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis

The phenotypic and genotypic spectrum of individuals with mono‐ or biallelic ANK3 variants

Aberrant phase separation and nucleolar dysfunction in rare genetic diseases

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

Etiology of Craniofacial and Cardiac Malformations in a Mouse Model of SF3B4-Related Syndromes

A mutation in PAK3 with a dual molecular effect deregulates the RAS/MAPK pathway and drives an X-linked syndromic phenotype

PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Neurodevelopmental disorders associated variants in ADAT3 disrupt the activity of the ADAT2/ADAT3 tRNA deaminase complex and impair neuronal migration.

Genotype–phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

A phenome-wide association study of methylated GC-rich repeats identifies a GCC repeat expansion in AFF3 associated with intellectual disability